Ding SR - Search Results

1

Prognostic value of hepatitis B viral infection in patients with nasopharyngeal carcinoma in the intensity-modulated radiotherapy era.

Zheng SH, Zhou S, Wang GN, Huang ZL, Liu SR, Chen C, Tao YL, Chang H, Ding SR, Liao RN, Chen C, Xia YF. Zheng SH, et al. Among authors: ding sr. Transl Cancer Res. 2021 Nov;10(11):4624-4635. doi: 10.21037/tcr-21-1340. Transl Cancer Res. 2021. PMID: 35116319 Free PMC article.

2

Effectiveness and safety of different amifostine regimens: Preliminary results of a phase II multicenter randomized controlled trial.

Chang H, Yi W, Wang X, Tao Y, Yang X, Chen C, Zhang W, Zhou S, Liu S, Li X, Ding S, Li J, Li G, Shao X, Liu Y, Song W, Xia Y. Chang H, et al. Chin J Cancer Res. 2018 Jun;30(3):307-314. doi: 10.21147/j.issn.1000-9604.2018.03.03. Chin J Cancer Res. 2018. PMID: 30046225 Free PMC article.

3

Surrogate endpoints shortening the therapeutic evaluation duration for different subgroups of patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: A retrospective analysis of 830 patients stratified by the 8th edition of the UICC/AJCC staging system and plasma Epstein-Barr viral.

Zhou S, Chen C, Liu SR, Tao YL, Chang H, Wang XH, Yang X, Zhang WW, Liu S, Ding SR, Wang GN, Xia YF. Zhou S, et al. Among authors: ding sr. J Cancer. 2018 Sep 8;9(18):3352-3360. doi: 10.7150/jca.25530. eCollection 2018. J Cancer. 2018. PMID: 30271496 Free PMC article.

4

O Blood Type Is Associated with Unfavorable Distant-metastasis-free Survival in Female Patients with Nasopharyngeal Carcinoma: A Retrospective Study of 2439 Patients from Epidemic Area.

Wang GN, Zhou S, Chen C, Chang H, Tao Y, Liu S, Wang XH, Zhang WW, Liu Y, Liu SR, Ding SR, Yang X, Ye ZQ, Gao YF, Xia YF. Wang GN, et al. Among authors: ding sr. J Cancer. 2019 Jan 30;10(5):1297-1306. doi: 10.7150/jca.28372. eCollection 2019. J Cancer. 2019. PMID: 30854139 Free PMC article.

5

The prognostic significance of PD-L1 and PD-1 expression in patients with nasopharyngeal carcinoma: a systematic review and meta-analysis.

Huang ZL, Liu S, Wang GN, Zheng SH, Ding SR, Tao YL, Chen C, Liu SR, Yang X, Chang H, Wang XH, Xia YF. Huang ZL, et al. Among authors: ding sr. Cancer Cell Int. 2019 May 22;19:141. doi: 10.1186/s12935-019-0863-5. eCollection 2019. Cancer Cell Int. 2019. PMID: 31139018 Free PMC article.

6

Prognostic role of programmed cell death ligand-1 expression in head and neck cancer treated with programmed cell death protein-1/programmed cell death ligand-1 inhibitors: A meta-analysis based on clinical trials.

Huang Z, Zheng S, Ding S, Wei Y, Chen C, Liu X, Li H, Xia Y. Huang Z, et al. J Cancer Res Ther. 2021 Jul;17(3):676-687. doi: 10.4103/jcrt.JCRT_1606_20. J Cancer Res Ther. 2021. PMID: 34269299 Free article.

7

Treatment and Survival Outcomes Associated With Platinum Plus Low-Dose, Long-term Fluorouracil for Metastatic Nasopharyngeal Carcinoma.

Zheng SH, Liu SR, Wang HB, Wei YH, Li H, Wang GN, Huang ZL, Ding SR, Chen C, Tao YL, Li XH, Glorieux C, Huang P, Wu YF, Xia YF. Zheng SH, et al. Among authors: ding sr. JAMA Netw Open. 2021 Dec 1;4(12):e2138444. doi: 10.1001/jamanetworkopen.2021.38444. JAMA Netw Open. 2021. PMID: 34902036 Free PMC article.

8

EBF3 reactivation by inhibiting the EGR1/EZH2/HDAC9 complex promotes metastasis via transcriptionally enhancing vimentin in nasopharyngeal carcinoma.

Ding S, Wang X, Lv D, Tao Y, Liu S, Chen C, Huang Z, Zheng S, Wei Y, Kang T, Xia Y. Ding S, et al. Cancer Lett. 2022 Feb 28;527:49-65. doi: 10.1016/j.canlet.2021.12.010. Epub 2021 Dec 11. Cancer Lett. 2022. PMID: 34906623 Free article.

9

Addition of chemoradiotherapy to palliative chemotherapy in de novo metastatic nasopharyngeal carcinoma: a real-world study.

Zheng SH, Wang YT, Liu SR, Huang ZL, Wang GN, Lin JT, Ding SR, Chen C, Xia YF. Zheng SH, et al. Among authors: ding sr. Cancer Cell Int. 2022 Jan 24;22(1):36. doi: 10.1186/s12935-022-02464-7. Cancer Cell Int. 2022. PMID: 35073926 Free PMC article.

10

DNTTIP1 promotes nasopharyngeal carcinoma metastasis via recruiting HDAC1 to DUSP2 promoter and activating ERK signaling pathway.

Ding S, Gao Y, Lv D, Tao Y, Liu S, Chen C, Huang Z, Zheng S, Hu Y, Chow LK, Wei Y, Feng P, Dai W, Wang X, Xia Y. Ding S, et al. EBioMedicine. 2022 Jul;81:104100. doi: 10.1016/j.ebiom.2022.104100. Epub 2022 Jun 8. EBioMedicine. 2022. PMID: 35689852 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters